AI Article Synopsis
Article Abstract
This federally funded program identifies gaps in research and provides support services for scientific, clinical, and translational research projects focused on the long-term effects of mild traumatic brain injury in veterans and active-duty service members.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363325 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Study protocol: Identifying transcriptional regulatory alterations of chronic effects of blast and disturbed sleep in United States Veterans.
PLoS One
March 2024
VA Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center (RMRVAMC), Aurora, CO, United States of America.
Injury related to blast exposure dramatically rose during post-911 era military conflicts in Iraq and Afghanistan. Mild traumatic brain injury (mTBI) is among the most common injuries following blast, an exposure that may not result in a definitive physiologic marker (e.g.
View Article and Find Full Text PDFAssociation of homelessness and diet on the gut microbiome: a United States-Veteran Microbiome Project (US-VMP) study.
mSystems
January 2024
Department of Veterans Affairs, Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC) for Suicide Prevention, Rocky Mountain Regional Veterans Affairs Medical Center (RMRVAMC), Aurora, Colorado, USA.
Military veterans account for 8% of homeless individuals living in the United States. To highlight associations between history of homelessness and the gut microbiome, we compared the gut microbiome of veterans who reported having a previous experience of homelessness to those from individuals who reported never having experienced a period of homelessness. Moreover, we examined the impact of the cumulative exposure of prior and current homelessness to understand possible associations between these experiences and the gut microbiome.
View Article and Find Full Text PDFModulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meeting.
Gut Microbes
December 2023
Surgery, Northwestern University, Evanston, IL, USA.
The present report summarizes the United States Department of Veterans Affairs (VA) field-based meeting titled "Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans." Our Veteran patient population experiences a high incidence of service-related chronic physical and mental health problems, such as infection, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), various forms of hematological and non-hematological malignancies, neurologic conditions, end-stage organ failure, requiring transplantation, and posttraumatic stress disorder (PTSD). We report the views of a group of scientists who focus on the current state of scientific knowledge elucidating the mechanisms underlying the aforementioned disorders, novel therapeutic targets, and development of new approaches for clinical intervention.
View Article and Find Full Text PDFDigital CBTI hubs as a treatment augmentation strategy in military clinics: study protocol for a pragmatic randomized clinical trial.
Trials
October 2023
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, USA.
Background: Chronic insomnia is the most prevalent sleep disorder among military service members, and it compromises readiness, performance, and physical and mental health. Cognitive behavioral treatment for insomnia (CBTI) is the standard of care for the treatment of insomnia recommended by the VA/DoD Clinical Practice Guideline, the American Academy of Sleep Medicine, and the American College of Physicians. CBTI is highly effective but has limited scalability.
View Article and Find Full Text PDFGenetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
J Am Soc Nephrol
November 2023
Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Article Synopsis
- African Americans are more susceptible to chronic kidney disease (CKD) partly due to high-risk variants in the APOL1 gene, specifically G1/G2 variants, but a different variant, p.N264K, appears to lower this risk significantly.
- A study of over 121,000 participants showed that those with the p.N264K variant had CKD and end-stage kidney disease (ESKD) risks comparable to individuals with low-risk APOL1 variants.
- Research indicates that p.N264K blocks harmful pore-forming functions of APOL1 high-risk variants, suggesting that drugs mimicking this protective mutation could potentially prevent or treat kidney disease related to APOL1.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!